ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 631451 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 631451; 2) Community: the network communities that were significantly associated with the response to NSC 631451; 3) Molecule: the relationships between components within communities and NSC 631451; 4) MDR: the compounds that were significantly associated with the NSC 631451.

NSC Compound Enrichment Correlation
NSC 754596 6-imino-3-methoxy 4-azaisoindole[2,1-a]quinoxaline 0.0247898374452139 0.073553071
NSC 75520 Thymidine, .alpha.,.alpha.,.alpha.-trifluoro- (8CI 9CI) 0.0247898374452139 0.16144135
NSC 760015 E)-1-(4-(quinazolin-4-ylamino)phenyl)-3-(2,4,6-trimethoxyphenyl)prop-2-en-1-one 0.0247898374452139 0.070632285
NSC 763232 Null 0.0247898374452139 0.21664663
NSC 763564 EMD-534085 0.0247898374452139 0.19961231
NSC 7811 Ammonium, [4-[[p-(dimethylamino)phenyl]imino]-2,5-cyclohexadien-1-ylidene]dimethyl-, chloride (8CI) 0.0247898374452139 0.19483578
NSC 85235 10.alpha.H-Ambrosa-2,11(13)-dien-12-oic acid, 6.beta.-hydroxy-4-oxo-, .gamma.-lactone (8CI) 0.0247898374452139 0.10059319
NSC 87500 Solacongestidine 0.0247898374452139 0.29963008
NSC 639617 Null 0.0252562667234375 0.2923478
NSC 691422 Acetonitrile, [11-(3,4-dimethoxyphenyl)-8,10-diphenyl- 8H,11H-pyrazolo[4',3':5,6]pyrano[3,2-e][1,2,4]-triazolo [1,5-c]pyrimidin-2-yl]- 0.0252562667234375 -0.055223702
Total:183  Current:128    [First] [Prev] [Next] [Last]